These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 745698

  • 21. Chronic lithium reduces [3H]spiroperidol binding in rat striatum.
    Rosenblatt JE, Pert A, Layton B, Bunney WE.
    Eur J Pharmacol; 1980 Oct 17; 67(2-3):321-2. PubMed ID: 7461036
    [No Abstract] [Full Text] [Related]

  • 22. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec 17; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 23. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
    Pedigo NW, Reisine TD, Fields JZ, Yamamura HI.
    Eur J Pharmacol; 1978 Aug 15; 50(4):451-3. PubMed ID: 699968
    [No Abstract] [Full Text] [Related]

  • 24. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H, Sudo K, Sano M.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):245-51. PubMed ID: 43256
    [Abstract] [Full Text] [Related]

  • 25. [3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivities.
    Andorn AC, Maguire ME.
    J Neurochem; 1980 Nov 16; 35(5):1105-13. PubMed ID: 6256500
    [Abstract] [Full Text] [Related]

  • 26. Demonstration of vascular dopamine receptors in membranes from rabbit renal artery using 3H-spiroperidol binding.
    Brodde OE.
    Experientia; 1981 Oct 15; 37(10):1099-101. PubMed ID: 6118286
    [No Abstract] [Full Text] [Related]

  • 27. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC, Kendrick PE.
    Biochem Pharmacol; 1980 Mar 15; 29(6):897-903. PubMed ID: 7387707
    [No Abstract] [Full Text] [Related]

  • 28. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G, Phan T, Uzan A.
    Life Sci; 1980 Apr 07; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract] [Full Text] [Related]

  • 29. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M, Vrsecká M, Krejcí I, Dlabac A.
    Eur J Pharmacol; 1987 Apr 07; 136(1):97-101. PubMed ID: 3297739
    [Abstract] [Full Text] [Related]

  • 30. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG, Friedhoff AJ, Bonnet KA.
    Biochem Biophys Res Commun; 1982 Mar 15; 105(1):117-20. PubMed ID: 6124243
    [No Abstract] [Full Text] [Related]

  • 31. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR, Molinoff PB.
    Mol Pharmacol; 1983 Mar 15; 23(2):303-9. PubMed ID: 6835199
    [Abstract] [Full Text] [Related]

  • 32. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
    Golembiowska-Nikitin K, Pilc A, Vetulani J.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May 15; 319(2):140-1. PubMed ID: 7202125
    [Abstract] [Full Text] [Related]

  • 33. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS, Tilson HA, Agrawal AK, Karoum F, Bondy SC.
    Neurotoxicology; 1982 Jul 15; 3(1):108-12. PubMed ID: 6890181
    [Abstract] [Full Text] [Related]

  • 34. Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
    Saiani L, Trabucchi M, Tonon GC, Spano PF.
    Neurosci Lett; 1979 Sep 15; 14(1):31-6. PubMed ID: 231228
    [Abstract] [Full Text] [Related]

  • 35. Lisuride hydrogen maleate: an ergoline with beta-adrenergic antagonist activity.
    Cote T, Munemura M, Kebabian J.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):303-6. PubMed ID: 43258
    [Abstract] [Full Text] [Related]

  • 36. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I, Snyder SH.
    Eur J Pharmacol; 1979 Jun 15; 56(3):277-81. PubMed ID: 38973
    [Abstract] [Full Text] [Related]

  • 37. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN.
    Eur J Pharmacol; 1984 Apr 13; 100(1):109-12. PubMed ID: 6723774
    [Abstract] [Full Text] [Related]

  • 38. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF, Lee JM, Fields JZ.
    Life Sci; 1982 May 03; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract] [Full Text] [Related]

  • 39. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB, Creese I, Snyder SH.
    J Neurochem; 1980 Mar 03; 34(3):669-76. PubMed ID: 6766497
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
    Tissari AH, Atzori L, Galdieri MT.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb 03; 322(1):89-91. PubMed ID: 6843693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.